Delivery Order SPE2DB24D1104-SPE2DB25FXXM7

Award Date 2/10/25
Potential Completion Date 2/11/25
Potential Value $40K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The award has a ceiling value of $14,080.32 and an ultimate completion date of February 11, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $46,350.81, is for the supply of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 6, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for DUPIXENT 200 MG/1.14 ML SYRING 1.14ML. The firm-fixed-price contract has a ceiling value of $6,837.84 and a period of performance through January 28, 2025. This award is not designated as a set-aside contract. The contract appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 200 MG/1.14 ML SYRING 1.14ML, a pharmaceutical product, with a ceiling value of $5,908.58 and an ultimate completion date of April 21, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $1,709.46, is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The contract is a Delivery Order placed under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The contract has a ceiling value of $5,751.34 and runs through January 6, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4562829067 - DUPIXENT 300 MG/2 ML SYRINGE 2ML. The firm-fixed-price delivery order has a ceiling value of $13,657.51 and a period of performance through November 16, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $3,418.92. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a total ceiling value of $1,991.29 and a performance period through May 28, 2024. The contract is structured as a Delivery Order, with a Firm Fixed Price pricing type. It is not designated as a Set-Aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,831.91, is for the provision of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product. The contract type is Firm Fixed Price, with a period of performance through December 12, 2023. This delivery order is part of a larger Indefinite Delivery Contract...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB25FXXM7
    Delivery Order

This is a Delivery Order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the provision of DUPIXENT 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $40,015.85. The contract has an ultimate completion date of February 11, 2025 and was awarded on February 10, 2025.

The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and there is no information provided about any subcontractors. The contract is a Firm Fixed Price type, with the DLA as the funding agency.

This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen Drug Corp holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/12/25, 10:46 AM